LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $242,000 | +11.0% | 1,566 | 0.0% | 0.04% | 0.0% |
Q3 2021 | $218,000 | +6.3% | 1,566 | 0.0% | 0.04% | +5.9% |
Q2 2021 | $205,000 | -14.2% | 1,566 | 0.0% | 0.03% | -22.7% |
Q1 2021 | $239,000 | +12.2% | 1,566 | 0.0% | 0.04% | -30.2% |
Q4 2018 | $213,000 | -50.5% | 1,566 | 0.0% | 0.06% | -41.7% |
Q3 2018 | $430,000 | +32.7% | 1,566 | 0.0% | 0.11% | +25.6% |
Q2 2018 | $324,000 | +51.4% | 1,566 | 0.0% | 0.09% | +45.8% |
Q4 2017 | $214,000 | +5.9% | 1,566 | -6.0% | 0.06% | +3.5% |
Q2 2017 | $202,000 | -1.0% | 1,666 | -16.6% | 0.06% | -19.7% |
Q3 2016 | $204,000 | -14.3% | 1,998 | 0.0% | 0.07% | -16.5% |
Q2 2016 | $238,000 | +11.2% | 1,998 | 0.0% | 0.08% | +3.7% |
Q1 2016 | $214,000 | -1.4% | 1,998 | 0.0% | 0.08% | -7.9% |
Q4 2015 | $217,000 | -33.8% | 1,998 | -81.0% | 0.09% | -41.8% |
Q1 2015 | $328,000 | – | 10,530 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |